107 related articles for article (PubMed ID: 9625433)
1. Cytotoxic effect of interferon-alpha2a in combination with all-trans retinoic acid or cisplatin in human ovarian carcinoma cell lines.
Jozan S; Courtade M; Mathieu-Boué A; Lochon I; Bugat R
Anticancer Drugs; 1998 Mar; 9(3):229-38. PubMed ID: 9625433
[TBL] [Abstract][Full Text] [Related]
2. Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines.
Caliaro MJ; Vitaux P; Lafon C; Lochon I; Néhmé A; Valette A; Canal P; Bugat R; Jozan S
Br J Cancer; 1997; 75(3):333-40. PubMed ID: 9020476
[TBL] [Abstract][Full Text] [Related]
3. The additive antiproliferative effect of all-trans retinoic acid and interferon-alpha2a on human cervical carcinoma cell lines is not associated with increased expression of retinoid receptors.
Wahlberg P; Einarsdottir M; Fex G; Rydell R
Anticancer Drugs; 1997 Jun; 8(5):522-8. PubMed ID: 9215617
[TBL] [Abstract][Full Text] [Related]
4. all-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cells.
Aebi S; Kröning R; Cenni B; Sharma A; Fink D; Los G; Weisman R; Howell SB; Christen RD
Clin Cancer Res; 1997 Nov; 3(11):2033-8. PubMed ID: 9815594
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effects of interferons -alpha and -beta in combination with 5-fluorouracil, cisplatin, and cis- and trans-retinoic acid in three human lung carcinoma cell lines.
Arbaje YM; Bittner G; Yingling JM; Storer B; Schiller JH
J Interferon Res; 1993 Feb; 13(1):25-32. PubMed ID: 8384234
[TBL] [Abstract][Full Text] [Related]
6. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
Lindner DJ; Borden EC; Kalvakolanu DV
Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
[TBL] [Abstract][Full Text] [Related]
7. In vitro radiosensitization of human cervical carcinoma cells by combined use of 13-cis-retinoic acid and interferon-alpha2a.
Ryu S; Kim OB; Kim SH; He SQ; Kim JH
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):869-73. PubMed ID: 9652851
[TBL] [Abstract][Full Text] [Related]
8. A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study.
Adamson PC; Matthay KK; O'Brien M; Reaman GH; Sato JK; Balis FM
Pediatr Blood Cancer; 2007 Oct; 49(5):661-5. PubMed ID: 16900483
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cisplatin cytotoxicity by human recombinant interferon-gamma in human ovarian cancer cell lines.
Nehme A; Julia AM; Jozan S; Chevreau C; Bugat R; Canal P
Eur J Cancer; 1994; 30A(4):520-5. PubMed ID: 8018412
[TBL] [Abstract][Full Text] [Related]
10. Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells.
Bonavida B; Tsuchitani T; Zighelboim J; Berek JS
Gynecol Oncol; 1990 Sep; 38(3):333-9. PubMed ID: 2227544
[TBL] [Abstract][Full Text] [Related]
11. Effect of retinoic acid and interferon alpha-2a on transitional cell carcinoma of bladder.
Zou C; Ramakumar S; Qian L; Zou C; Zang R; Wang J; Grossman HB; Lotan R; Liebert M
J Urol; 2005 Jan; 173(1):247-51. PubMed ID: 15592090
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer.
Zhang Y; Guan DX; Shi J; Gao H; Li JJ; Zhao JS; Qiu L; Liu J; Li N; Guo WX; Xue J; Zhou FG; Wu MC; Wang HY; Xie D; Cheng SQ
J Hepatol; 2013 Dec; 59(6):1255-63. PubMed ID: 23867314
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum.
Uslu R; Bonavida B
Cancer; 1996 Feb; 77(4):725-32. PubMed ID: 8616765
[TBL] [Abstract][Full Text] [Related]
14. Effects of biological response modifiers on ovarian carcinoma cell lines.
Marth C; Helmberg M; Mayer I; Fuith LC; Daxenbichler G; Dapunt O
Anticancer Res; 1989; 9(2):461-7. PubMed ID: 2502063
[TBL] [Abstract][Full Text] [Related]
15. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E
Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278
[TBL] [Abstract][Full Text] [Related]
16. Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients.
Toma S; Raffo P; Nicolo G; Canavese G; Margallo E; Vecchio C; Dastoli G; Iacona I; Regazzi-Bonora M
Int J Oncol; 2000 Nov; 17(5):991-1000. PubMed ID: 11029503
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R
Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha enhances the cytotoxic and cytostatic activities of chemotherapeutic drugs in human myeloid leukemia cells.
Hassan HT; Grell S; Borrmann-Danso U; Freund M
J Interferon Cytokine Res; 1996 Feb; 16(2):139-46. PubMed ID: 8742366
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha and -gamma in combination with chemotherapeutic drugs: in vitro sensitivity studies in four human mesothelioma cell lines.
Hand AM; Husgafvel-Pursiainen K; Pelin K; Vallas M; Suitiala T; Ekman A; Mattson M; Mattson K; Linnainmaa K
Anticancer Drugs; 1992 Dec; 3(6):687-94. PubMed ID: 1288739
[TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assay.
Saito T; Berens ME; Welander CE
Cancer Chemother Pharmacol; 1987; 19(3):233-9. PubMed ID: 3107848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
